Clinical Trials Logo

Attention Deficit Disorder (ADD) clinical trials

View clinical trials related to Attention Deficit Disorder (ADD).

Filter by:
  • None
  • Page 1

NCT ID: NCT04634006 Recruiting - Clinical trials for Attention Deficit Hyperactivity Disorder (ADHD)

Home-Based tDCS in Children With ADHD: A Randomized, Sham-Controlled tDCS and fNIRS Study

Start date: November 5, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the efficacy of twenty daily sessions of home-based tDCS over the left DLPFC, right IFG on attention and response inhibition in children with ADHD. Investigators hypothesize that multiple sessions of tDCS will induce a greater and long-term effect on attentional and/or inhibitory response in children with ADHD. In addition, this study seeks to get a better understanding of the mechanisms of tDCS using fNIRS.

NCT ID: NCT00418262 Recruiting - Clinical trials for Fetal Alcohol Syndrome

Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD

Start date: June 2006
Phase: Phase 3
Study type: Interventional

Determine if atomoxetine is safe and well tolerated by children with fetal alcohol syndrome.

NCT ID: NCT00417794 Completed - Clinical trials for Fetal Alcohol Syndrome

Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD

B4Z-MC-X017
Start date: August 2005
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine if atomoxetine hydrochloride improves inattention, hyperactivity, and impulsivity problems in children exposed to alcohol during birth.